
Vogmax 0.3mg Tablet
Marketer
Shinemax Pharma India Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Vogmax 0.3mg Tablet
Diabetol 0.3mg tablets manage type 2 diabetes by regulating postprandial hyperglycemia. It's prescribed when dietary modifications and other comparable medications prove insufficient in controlling elevated blood glucose. Diabetol 0.3mg should be administered immediately before meals; dosage and frequency are determined individually by your physician for optimal glycemic control. Discontinuation should only occur under medical supervision, as abrupt cessation can elevate blood sugar, potentially causing severe complications such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include abdominal discomfort, bloating, anorexia, constipation, and diarrhea. Report persistent or troublesome side effects to your physician. While Diabetol 0.3mg itself doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose tablets are the appropriate treatment for hypoglycemic episodes; sucrose is ineffective. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice prior to use. Complete disclosure of all other medications is crucial for safe use. Excessive alcohol consumption should be avoided due to the heightened hypoglycemia risk.
Uses of Vogmax 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vogmax 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogmax 0.3mg Tablet on an empty stomach.
Common Side effects of Vogmax 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogmax 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogmax 0.3mg tablets should be taken on an empty stomach.
How Vogmax 0.3mg Tablet works:
Glucovance 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating post-prandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Vogmax 0.3mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Vogmax 0.3mg tablets is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vogmax 0.3mg tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant hazard from this medication.
DrivingSAFE
Driving ability is typically unaffected by Vogmax 0.3mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Vogmax 0.3mg tablets cautiously. Dosage modification for Vogmax 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vogmax 0.3mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Vogmax 0.3mg Tablet :
Omit any missed Vogmax 0.3mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vogmax 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Behavior Class | Alpha-glucosidase inhibitors |
